Setmelanotide
Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity
Rhythm · Phase 3 · Completed · Enrollment 15
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Setmelanotide | 8 participants | 2 participants | 7 participants | n/r | 1 |
A count stays a count. This page does not turn a count into a percent.